MSCI全球小型股指数调整在即 映恩生物等企业将被纳入

Core Insights - MSCI announced the results of its quarterly index review for August 2025, including the addition of several companies, such as InnoCare Pharma (Suzhou) Co., Ltd., to the MSCI Global Small Cap Index [1] Group 1 - The adjustment will take effect after the market closes on August 26, 2025 [1] - The inclusion of new companies is expected to lead to increased trading volume during the closing auction on the inclusion day, driven by passive fund buying [1] - While the short-term impact on stock prices is limited, the long-term benefits are anticipated in terms of funding, valuation, and brand recognition [1]